In non-small cell lung cancer (NSCLC) patients, abnormal expressions of serum miRNA-21, along with Carcinoembryonic antigen (CEA), Cytokeratins 19 (CYFRA21-1), and Neuron specific enolase (NSE) are noted. The gene discussed is ENO2; the disease is non-small cell lung carcinoma.